There is significant momentum to change marijuana’s status as a Schedule I drug under the Controlled Substances Act; however, there is disagreement as to whether it should be placed on a different schedule or removed as a federally controlled substance entirely. Andrew Kline and the other panelists will debate marijuana’s ultimate fate in light of known science and other drugs, substances, and chemicals under the purview of the Drug Enforcement Agency.